Please login to the form below
medicines
This page shows the latest medicines news and features for those working in and with pharma, biotech and healthcare.
FDA sets January decision date for Xalkori in ALK-positive lymphoma
In addition to the FDA priority review, the European Medicines Agency (EMA) has agreed on a paediatric investigational plan for Xalkori, including the treatment of paediatric patients with relapsed or refractory
Latest news
-
Stop that!
You might think better if you were less of a scientist
-
EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
Gene therapy has been given a PRIME designation. Biotech company bluebird bio has been awarded a priority medicines (PRIME) designation by the European Medicines Agency (EMA) for its gene therapy LentiGlobin ... Even with recent progress to deliver new
-
FDA hands BMS and bluebird bio a priority review for ide-cel
Ide-cel has been awarded a Priority Medicines (PRIME) designation by the European Medicines Agency (EMA), and BMS and bluebird bio also plan to submit the CAR-T therapy for approval
-
BMS eyes approval for second Opdivo combo in kidney cancer
This includes in the EU, where the European Medicines Agency (EMA) recently validated the completion of BMS/Exelixis’ submissions and the beginning of the agency’s centralised review process of the
-
AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
Medicine. These detailed results showed that fewer patients treated with Tagrisso in the adjuvant setting had recurrence event or death compared to placebo – 11% and 46% respectively. ... The striking new data shows that Tagrisso prevents the
More from news
Approximately 171 fully matching, plus 4,033 partially matching documents found.
Latest Intelligence
-
Could formulary intelligence be your brand differentiator?
Abasaglar – a biosimilar to Lantus (diabetes), offering a money-saving value proposition for medicines management. ... Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.
-
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
In fact, this is the most exciting time to work in medicines.
-
Exploiting the value of data in pharma
Accelerate development. Again, in March, the Innovative Medicines Initiative (IMI) issued a call for Innovation Actions into detections, therapeutics, antivirals and diagnostics (not vaccines).
-
We need to keep learning to keep innovating
We are privileged to meet the people striving to develop new medicines to make people’s lives better by treating or curing diseases. ... Let’s not forget, either, that the huge strides our colleagues in R&D are making are transforming the way we
-
AI: the smart money is on the smart thinking
Another recent case, separate to COVID-19, would be that of Insilico Medicine. ... achieve. Insilico Medicine was able to do this through development of an AI drug discovery system: GENTRL (Generative Tensorial Reinforcement Learning).
More from intelligence
Approximately 21 fully matching, plus 557 partially matching documents found.
Latest appointments
-
New hires at EMA, Gilead and BeiGene
European Medicines Agency (EMA). The European Medicines Agency (EMA) management board has nominated Emer Cooke (pictured above) as its new executive director. ... Raitt professor of medicine and clinical chief in the division of immunology and
-
NICE looks internally for new chief executive
Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a consultant in public health medicine.
-
Genmab hires first chief operating officer
Most recently, he led Bristol-Myers Squibb’s US innovative medicines unit, where he managed a team of over 1000 people focused on immunology and cardiovascular diseases.
-
Four Health announces a pair of internal promotions
role of the NHS in public health and prevention medicine.
-
Porterhouse announces members of medical advisory group
She graduated from St Bartholomew’s and the London School of Medicine and Dentistry in 2001, working as a pathologist in the NHS until 2015. ... She is a fully qualified medical doctor, with MBChB Medicine and BSc Biochemistry qualifications gained
More from appointments
Approximately 10 fully matching, plus 353 partially matching documents found.
Latest from PMHub
-
Live Webinar: Telemedicine & the Digitization of Medicine post COVID-19
Geoffrey Mount Varner. In this Fireside Chat, Natalie Yeadon will host a panel discussion on telehealth and the digitization of medicine post-COVID-19.
-
Live Webinar: Innovative Medical Solutions for Postponing & Undoing Age-Related Disease
regenerative medicine to postpone aging-derived debilitation and death.
-
emotive supports Rare Disease Day 2019
On 20th February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD). . ... work we do in such an innovative area of medicine. .
-
Mednet Group’s growth spurt
ve settled in quickly with the team being so friendly and I’m looking forward to getting involved in a range of projects in the field of healthcare and medicine.”.
-
After a busy first quarter, emotive welcomes five new team members
Fiona has a BSc in Medical Physics which involved studying subjects such as Radiotherapy, Nuclear Medicine and Medical Imaging techniques and wrote her dissertation in Ultrasound diagnostics.
More from PMHub
Approximately 34 fully matching, plus 314 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
